Logo image of NCBS

NICOLET BANKSHARES INC (NCBS) Stock Fundamental Analysis

NASDAQ:NCBS - Nasdaq - US65406E1029 - Common Stock

78.01  +2.66 (+3.53%)

Fundamental Rating

2

Overall NCBS gets a fundamental rating of 2 out of 10. We evaluated NCBS against 396 industry peers in the Banks industry. NCBS has a bad profitability rating. Also its financial health evaluation is rather negative. NCBS is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NCBS was profitable.
NCBS Yearly Net Income VS EBIT VS OCF VS FCFNCBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA 0.91%
ROE 7.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCBS Yearly ROA, ROE, ROICNCBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

The Operating Margin and Gross Margin are not available for NCBS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 27.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCBS Yearly Profit, Operating, Gross MarginsNCBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for NCBS has been increased compared to 1 year ago.
Compared to 1 year ago, NCBS has a worse debt to assets ratio.
NCBS Yearly Shares OutstandingNCBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
NCBS Yearly Total Debt VS Total AssetsNCBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

A Debt/Equity ratio of 0.23 indicates that NCBS is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
NCBS Yearly LT Debt VS Equity VS FCFNCBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

8

3. Growth

3.1 Past

The earnings per share for NCBS have decreased strongly by -16.02% in the last year.
NCBS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.36% yearly.
NCBS shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.00%.
The Revenue has been growing by 18.91% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.02%
EPS 3Y10.11%
EPS 5Y17.36%
EPS Q2Q%-2.86%
Revenue 1Y (TTM)21%
Revenue growth 3Y15.55%
Revenue growth 5Y18.91%
Sales Q2Q%37.36%

3.2 Future

The Earnings Per Share is expected to grow by 21.67% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 35.03% on average over the next years. This is a very strong growth
EPS Next Y32.09%
EPS Next 2Y22.64%
EPS Next 3Y21.59%
EPS Next 5Y21.67%
Revenue Next Year57.51%
Revenue Next 2Y34.89%
Revenue Next 3Y34.54%
Revenue Next 5Y35.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NCBS Yearly Revenue VS EstimatesNCBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
NCBS Yearly EPS VS EstimatesNCBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.31, NCBS is valued correctly.
The average S&P500 Price/Earnings ratio is at 27.35. NCBS is valued slightly cheaper when compared to this.
NCBS is valuated reasonably with a Price/Forward Earnings ratio of 9.43.
NCBS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.54.
Industry RankSector Rank
PE 14.31
Fwd PE 9.43
NCBS Price Earnings VS Forward Price EarningsNCBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCBS Per share dataNCBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NCBS's earnings are expected to grow with 21.59% in the coming years.
PEG (NY)0.45
PEG (5Y)0.82
EPS Next 2Y22.64%
EPS Next 3Y21.59%

More info and screens

0

5. Dividend

5.1 Amount

NCBS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NICOLET BANKSHARES INC

NASDAQ:NCBS (5/23/2022, 8:00:02 PM)

78.01

+2.66 (+3.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-19 2022-04-19/amc
Earnings (Next)07-18 2022-07-18
Inst Owners51.76%
Inst Owner Change-0.07%
Ins Owners4.18%
Ins Owner Change0%
Market Cap1.04B
Analysts81.82
Price Target110.16 (41.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.31
Fwd PE 9.43
P/S 4.28
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.45
EY6.99%
EPS(NY)8.27
Fwd EY10.6%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS18.24
BVpS62.45
TBVpSN/A
PEG (NY)0.45
PEG (5Y)0.82
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 7.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 27.25%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.02%
EPS 3Y10.11%
EPS 5Y17.36%
EPS Q2Q%-2.86%
EPS Next Y32.09%
EPS Next 2Y22.64%
EPS Next 3Y21.59%
EPS Next 5Y21.67%
Revenue 1Y (TTM)21%
Revenue growth 3Y15.55%
Revenue growth 5Y18.91%
Sales Q2Q%37.36%
Revenue Next Year57.51%
Revenue Next 2Y34.89%
Revenue Next 3Y34.54%
Revenue Next 5Y35.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A